Short-Term Intraocular Pressure Changes After 0.1% Fluorometholone in Pediatric Strabismus Surgery

Kenta Hozumi1, Teiji Yagasaki1,2, Yoshimi Yokoyama1

  • 1Department of Ophthalmology, Japan Community HealthCare Organization (JCHO) Chukyo Hospital, Nagoya, Aichi, Japan.

Insights

Short-term use of fluorometholone ophthalmic solution (FM) after pediatric strabismus surgery did not significantly increase intraocular pressure (IOP). This anti-inflammatory treatment is considered safe for children, with minimal IOP elevation observed post-surgery.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Strabismus surgery in children can lead to postoperative inflammation.
  • Intraocular pressure (IOP) monitoring is crucial after ophthalmic procedures.
  • Fluorometholone ophthalmic solution (FM) is used for its anti-inflammatory properties.

Purpose of the Study:

  • To evaluate the effect of 0.1% fluorometholone ophthalmic solution (FM) on intraocular pressure (IOP) in pediatric patients following strabismus surgery.

Main Methods:

  • A study included 224 children (<15 years) who underwent strabismus surgery.
  • Participants received FM four times daily for one month postoperatively.
  • Intraocular pressure was measured using a non-contact tonometer, assessing pre- and postoperative IOP, and changes.

Main Results:

  • Mean pre- and postoperative IOPs were 14.7 ± 2.4 mmHg and 14.8 ± 3.3 mmHg, respectively (p = 0.552).
  • 3.6% of eyes showed an IOP increase of >6 mmHg.
  • 6.3% of eyes had a postoperative IOP >20 mmHg.

Conclusions:

  • Short-term use of FM did not significantly elevate IOP in pediatric patients post-strabismus surgery.
  • FM appears to be a safe option for managing inflammation after this procedure in children.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
191
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K